Back

Clinical outcomes of edoxaban treatment without parenteral anticoagulation therapy for acute venous thromboembolism: Insight from the COMMAND VTE Registry-2

2 September 2024 (09:00 - 09:50)
Organised by: Logo
Congress Presentation Part of: Venous thromboembolism: international perspectives Venous Thromboembolism ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Mr Yuta Tsujisaka

Kyoto University Graduate School of Medicine, Kyoto (Japan)

9 More presentations in this session

Presentation thumbnail
Application of DOAC Score for the risk-stratification of major bleeding in patients with venous thromboembolism on direct oral anticoagulants: insight from the COMMAND VTE Registry-2
Doctor Y. Nishimoto (Toyonaka, JP)
Abstract Slides Video
Presentation thumbnail
Types of pulmonary hypertension and prognosis in COVID-19: 18-months analysis of BNP-PL national database.
Doctor A. Mamzer (Lodz, PL)
Abstract Slides Video
Presentation thumbnail
A novel dynamic risk score to predict Clinically Significant Bleeding (CSB) after 3 months of anticoagulation in patients with incident Venous ThromboEmbolism (VTE) and without active cancer.
Doctor A. Cohen (London, GB)
Abstract Slides Video
Presentation thumbnail
Validation of the PESI-Echo score: as a prognostic tool for mortality in acute pulmonary thromboembolism in Mexican population.
Slides Video
Presentation thumbnail
Sex differences in in-hospital management and outcomes of patients with acute pulmonary embolism
Professor C. Becattini (Perugia, IT)
Abstract Slides

Access the full session

Session thumbnail
Venous thromboembolism: international perspectives

The Event

Event poster

ESC Congress 2024

2 September 2024 09:00 CET
You may be interested in
thumbnail
Congress Presentation
The initial high-dose versus maintenance-dose anticoagulation therapy with direct oral anticoagulants for cancer-associated venous thromboembolism: from the COMMAND VTE Registry-2
thumbnail
Congress Presentation
The influence of concomitant antiplatelet therapy in venous thromboembolism patients treated with anticoagulants in the DOAC era: insight from the COMMAND VTE Registry-2
thumbnail
Congress Presentation
Navigating challenging clinical scenarios in the management of patients with cancer-associated venous thromboembolism

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources